CS logo
small CS logo
Johns Hopkins Asthma And Allergy Center

Baltimore, Maryland, United States
Hospital department in Baltimore, Maryland
5501 Hopkins Bayview Cir, Baltimore, MD 21224

About Johns Hopkins Asthma And Allergy Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Johns Hopkins University
16
Eli Lilly and Company
2
Amgen
1
Arena Pharmaceuticals
1
Boehringer Ingelheim
1
Bristol-Myers Squibb
1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.
1
Genentech, Inc.
1
Hoffmann-La Roche
1
National Institute of Allergy and Infectious Diseases (NIAID)
1
Novartis
1
Total Rows: 12

Clinical Trials at Johns Hopkins Asthma And Allergy Center


During the past decade, Johns Hopkins Asthma And Allergy Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 14 clinical trials were completed, i.e. on average, 127.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100112222114400116633001122Started TrialsCompleted Trails201520162017201820192020202102468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
2004-11-01
Completed
113
Effect of Anti-IgE in Chronic Urticaria
2004-11-01
2007-09-01
Completed
20
Effect of Anti-IgE in Non-Allergic Asthma
2005-04-01
2009-09-01
Terminated
29
Reducing Asthma Disparities by Improving Provider-Patient Communication
2005-05-01
2012-12-01
Completed
350
Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
2004-05-01
2007-12-01
Completed
50
A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
2007-04-01
2010-01-19
Terminated
33
26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
2007-04-01
2008-08-01
Completed
2,059
The Effect of Omalizumab on Responses to Cat Allergen Challenge
2007-07-01
2009-01-01
Completed
18

Rows per page:

1–28 of 28

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Johns Hopkins Asthma And Allergy Center" #1 sponsor was "Johns Hopkins University" with 16 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Arena Pharmaceuticals" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins Asthma And Allergy Center" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Centers for Medicare and Medicaid Services" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJohns Hopkins University: 16Johns Hopkins University: 16Eli Lilly and Company: 2Eli Lilly and Company: 2Amgen: 1Amgen: 1Arena Pharmaceuticals: 1Arena Pharmaceuticals: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1GB001, Inc, a whollyowned subsidiary ofGossamer Bio, Inc.: 1GB001, Inc, a whollyowned subsidiary ofGossamer Bio, Inc.: 1Genentech, Inc.: 1Genentech, Inc.: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1National Institute ofAllergy and InfectiousDiseases (NIAID): 1National Institute ofAllergy and InfectiousDiseases (NIAID): 1

Created with Highcharts 11.1.0Top CollaboratorsGenentech, Inc.: 3Genentech, Inc.: 3National Institute ofAllergy and InfectiousDiseases (NIAID): 3National Institute ofAllergy and InfectiousDiseases (NIAID): 3National Heart, Lung,and Blood Institute(NHLBI): 2National Heart, Lung,and Blood Institute(NHLBI): 2AstraZeneca: 1AstraZeneca: 1Centers for Medicareand Medicaid Services:1Centers for Medicareand Medicaid Services:1Hill-Rom: 1Hill-Rom: 1Immune ToleranceNetwork (ITN): 1Immune ToleranceNetwork (ITN): 1Incyte Corporation: 1Incyte Corporation: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1National Institutes ofHealth (NIH): 1National Institutes ofHealth (NIH): 1

Clinical Trials Conditions at Johns Hopkins Asthma And Allergy Center


According to Clinical.Site data, the most researched conditions in "Johns Hopkins Asthma And Allergy Center" are "Asthma" (6 trials), "COPD" (3 trials), "Allergic Rhinitis" (2 trials), "Cat Allergy" (2 trials) and "Chronic Bronchitis" (2 trials). Many other conditions were trialed in "Johns Hopkins Asthma And Allergy Center" in a lesser frequency.

Clinical Trials Intervention Types at Johns Hopkins Asthma And Allergy Center


Most popular intervention types in "Johns Hopkins Asthma And Allergy Center" are "Drug" (19 trials), "Device" (5 trials), "Other" (5 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Omalizumab" (4 trials), "omalizumab" (2 trials), "AMG 157" (1 trials) and "AMG 157 Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Johns Hopkins Asthma And Allergy Center


The vast majority of trials in "Johns Hopkins Asthma And Allergy Center" are 28 trials for "All" genders.

Clinical Trials Status at Johns Hopkins Asthma And Allergy Center


Currently, there are NaN active trials in "Johns Hopkins Asthma And Allergy Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Johns Hopkins Asthma And Allergy Center, undefined suspended trials, and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Johns Hopkins Asthma And Allergy Center, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 14Phase 2: 14Phase 4: 5Phase 4: 5Phase 3: 3Phase 3: 3Not Applicable: 2Not Applicable: 2Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 19Completed: 19Terminated: 6Terminated: 6Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1